{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:27:17Z","timestamp":1788920837002,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1006\/jsre.2002.6540","type":"journal-article","created":{"date-parts":[[2003,1,9]],"date-time":"2003-01-09T12:12:55Z","timestamp":1042114375000},"page":"148-156","source":"Crossref","is-referenced-by-count":6,"title":["Adjuvant Effect of a Flt3 Ligand (FL) Gene-Transduced Xenogeneic Cell Line in a Murine Colon Cancer Model"],"prefix":"10.1006","volume":"108","author":[{"given":"Eugene M.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthukumaran","family":"Sivanandham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos I.","family":"Stavropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc K.","family":"Wallack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/jsre.2002.6540_RF1","first-page":"1641","article-title":"Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR\/CSFIR family","volume":"6","author":"Rosnet","year":"1991","journal-title":"Oncogene"},{"key":"10.1006\/jsre.2002.6540_RF2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/0092-8674(91)90010-V","article-title":"A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations","volume":"65","author":"Matthews","year":"1991","journal-title":"Cell"},{"key":"10.1006\/jsre.2002.6540_RF3","first-page":"815","article-title":"Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene","volume":"8","author":"Lyman","year":"1993","journal-title":"Oncogene"},{"key":"10.1006\/jsre.2002.6540_RF4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0092-8674(93)90325-K","article-title":"Molecular cloning of a ligand for the flt3\/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells","volume":"75","author":"Lyman","year":"1993","journal-title":"Cell"},{"key":"10.1006\/jsre.2002.6540_RF5","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1182\/blood.V83.10.2795.2795","article-title":"Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells","volume":"83","author":"Lyman","year":"1994","journal-title":"Blood"},{"key":"10.1006\/jsre.2002.6540_RF6","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood.V87.9.3563.bloodjournal8793563","article-title":"Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38\u2212 cells and maintains progenitor cells in vitro","volume":"87","author":"Shah","year":"1996","journal-title":"Blood"},{"key":"10.1006\/jsre.2002.6540_RF7","first-page":"1165","article-title":"Structural analysis of human and murine flt3 ligand genomic loci","volume":"11","author":"Lyman","year":"1995","journal-title":"Oncogene"},{"key":"10.1006\/jsre.2002.6540_RF8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/cyto.1999.0540","article-title":"Flt3 ligand (FL) and its influence on immune reactivity","volume":"12","author":"Antonysamy","year":"2000","journal-title":"Cytokine"},{"key":"10.1006\/jsre.2002.6540_RF9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-0609.1998.tb01003.x","article-title":"Flt-3 ligand mobilizes hematopoietic primitive and committed progenitor cells into blood in mice","volume":"60","author":"Ashihara","year":"1998","journal-title":"Eur. J. Haematol."},{"key":"10.1006\/jsre.2002.6540_RF10","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1200\/JCO.2000.18.23.3883","article-title":"Preoperative mobilization of circulating dendritic cells by flt3 ligand administration to patients with metastatic colon cancer","volume":"18","author":"Morse","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/jsre.2002.6540_RF11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00062752-199805000-00008","article-title":"Biologic effects and potential clinical applications of flt3 ligand","volume":"5","author":"Lyman","year":"1998","journal-title":"Curr. Opin. Hematol."},{"key":"10.1006\/jsre.2002.6540_RF12","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1182\/blood.V89.9.3186","article-title":"Synergistic effect of flt-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice","volume":"89","author":"Sudo","year":"1997","journal-title":"Blood"},{"key":"10.1006\/jsre.2002.6540_RF13","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1182\/blood.V89.11.3998","article-title":"Flt-3 ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potential","volume":"89","author":"Molineux","year":"1997","journal-title":"Blood"},{"key":"10.1006\/jsre.2002.6540_RF14","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4049\/jimmunol.163.3.1289","article-title":"Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo","volume":"163","author":"Borges","year":"1999","journal-title":"J. Immunol."},{"key":"10.1006\/jsre.2002.6540_RF15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00002371-200001000-00007","article-title":"Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-\u03b1 are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells","volume":"23","author":"Ferlazzo","year":"2000","journal-title":"J Immunother."},{"key":"10.1006\/jsre.2002.6540_RF16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/cyto.2000.0806","article-title":"Flt3 ligand pretreatment promotes protective immunity to Listeria monoctyogenes","volume":"13","author":"Gregory","year":"2001","journal-title":"Cytokine"},{"key":"10.1006\/jsre.2002.6540_RF17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1128\/IAI.69.2.673-680.2001","article-title":"Pretreatment with recombinant flt3 ligand partially protects against progressivecutaneous Leishmaniasis in susceptible Balb\/c mice","volume":"69","author":"Kremer","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1006\/jsre.2002.6540_RF18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1365-2567.2001.01180.x","article-title":"Reduced herpes simplex virus type 1 latency in flt-3 ligand-treated mice is associated with enhanced numbers of natural killer and dendritic cells","volume":"102","author":"Smith","year":"2001","journal-title":"Immunology"},{"key":"10.1006\/jsre.2002.6540_RF19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00002371-200201000-00003","article-title":"Antitumor effects of flt3 ligand in transplanted murine tumor models","volume":"25","author":"Averbook","year":"2002","journal-title":"J. Immunother."},{"key":"10.1006\/jsre.2002.6540_RF20","first-page":"1895","article-title":"Antileukemic activity of flt3 ligand in murine leukemia","volume":"60","author":"Wang","year":"2000","journal-title":"Cancer Res."},{"key":"10.1006\/jsre.2002.6540_RF21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nm0697-625","article-title":"Flt3 ligand induces tumor regression and antitumor immune responses in vivo","volume":"3","author":"Lynch","year":"1997","journal-title":"Nat. Med."},{"key":"10.1006\/jsre.2002.6540_RF22","first-page":"380","article-title":"Flt3 ligand administration inhibits tumor growth in murine melanoma and lymphoma","volume":"58","author":"Esche","year":"1998","journal-title":"Cancer Res."},{"key":"10.1006\/jsre.2002.6540_RF23","first-page":"2081","article-title":"Flt3-ligand induces transient tumor regression in an ectopic treatment model of major histocompatibility complex-negative prostrate cancer","volume":"60","author":"Ciavarra","year":"2000","journal-title":"Cancer Res."},{"key":"10.1006\/jsre.2002.6540_RF24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1615\/CritRevImmunol.v18.i1-2.110","article-title":"Induction of dendritic cells (DC) by flt3 ligand (FL) promotes the generation of tumor-specific immune responses in vivo","volume":"18","author":"Lynch","year":"1998","journal-title":"Crit. Rev. Immunol."},{"key":"10.1006\/jsre.2002.6540_RF25","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.4049\/jimmunol.161.11.6164","article-title":"Flt3-ligand administration inhibits liver metastases: Role of NK cells","volume":"161","author":"Peron","year":"1998","journal-title":"J. Immunol."},{"key":"10.1006\/jsre.2002.6540_RF26","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood.V97.5.1474","article-title":"In vitro tumor-pulsed or in vivo flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice","volume":"97","author":"Pawlowska","year":"2001","journal-title":"Blood"},{"key":"10.1006\/jsre.2002.6540_RF27","doi-asserted-by":"crossref","first-page":"8809","DOI":"10.1073\/pnas.141226398","article-title":"Altered peptide ligand vaccination with flt3 ligand expanded dendritic cells for tumor immunotherapy","volume":"98","author":"Fong","year":"2001","journal-title":"PNAS"},{"key":"10.1006\/jsre.2002.6540_RF28","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1089\/10430349950017130","article-title":"Flt3 ligand antitumor activity in a murine breast cancer model: A comparison with granulocyte-macrophage colony-stimulating factor and a potential mechanism of action","volume":"10","author":"Braun","year":"1999","journal-title":"Human Gene Ther."},{"key":"10.1006\/jsre.2002.6540_RF29","first-page":"3511","article-title":"Antitumor activity and immunotherapeutic properties of flt3-ligand in a murine breast cancer model","volume":"57","author":"Chen","year":"1997","journal-title":"Cancer Res."},{"key":"10.1006\/jsre.2002.6540_RF30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00262-001-0256-0","article-title":"Therapeutic effect of colon tumor cells expressing flt-3 ligand plus systemic IL-2 in mice with syngeneic colon cancer","volume":"51","author":"Sivanandham","year":"2002","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1006\/jsre.2002.6540_RF31","first-page":"1881","article-title":"Sustained cytokine delivery for anticancer vaccination: Liposomes as alternative for gene-transfected tumor cells","volume":"4","author":"Koppenhagen","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1006\/jsre.2002.6540_RF32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/jsre.2001.6302","article-title":"Xenogeneic DNA immunization in melanoma models for minimal residual disease","volume":"102","author":"Hawkins","year":"2002","journal-title":"J. Surg. Res."},{"key":"10.1006\/jsre.2002.6540_RF33","first-page":"8769","article-title":"Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors","volume":"61","author":"Iwadate","year":"2001","journal-title":"Cancer Res."},{"key":"10.1006\/jsre.2002.6540_RF34","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/80506","article-title":"Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine","volume":"6","author":"Wei","year":"2000","journal-title":"Nat. Med."},{"key":"10.1006\/jsre.2002.6540_RF35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1634\/theoncologist.5-1-68","article-title":"Cellular suicide therapy of malignant disease","volume":"5","author":"Link","year":"2000","journal-title":"Oncologist"},{"key":"10.1006\/jsre.2002.6540_RF36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00008390-199608000-00004","article-title":"Allogeneic murine melanoma cell vaccine: A model for the development of human allogeneic cancer vaccine","volume":"6","author":"Knight","year":"1996","journal-title":"Melanoma Res."},{"key":"10.1006\/jsre.2002.6540_RF37","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.4049\/jimmunol.167.12.7150","article-title":"Dendritic cell-based xenoantigen vaccination for prostrate cancer immunotherapy","volume":"167","author":"Fong","year":"2001","journal-title":"J. Immunol."},{"key":"10.1006\/jsre.2002.6540_RF38","first-page":"2802","article-title":"Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity","volume":"59","author":"Melcher","year":"1999","journal-title":"Cancer Res."},{"key":"10.1006\/jsre.2002.6540_RF39","doi-asserted-by":"crossref","first-page":"11545","DOI":"10.1073\/pnas.191112198","article-title":"Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen","volume":"98","author":"Wei","year":"2001","journal-title":"PNAS"},{"key":"10.1006\/jsre.2002.6540_RF40","first-page":"2267","article-title":"Characterization of tumorigenicity, mortality, metastasis, and splenomegaly of two cultured murine colon lines","volume":"41","author":"Sato","year":"1981","journal-title":"Cancer Res."},{"key":"10.1006\/jsre.2002.6540_RF41","first-page":"2434","article-title":"Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure","volume":"35","author":"Corbett","year":"1975","journal-title":"Cancer Res."},{"key":"10.1006\/jsre.2002.6540_RF42","first-page":"3239","article-title":"Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or flt3-ligand","volume":"60","author":"Mach","year":"2000","journal-title":"Cancer Res."},{"key":"10.1006\/jsre.2002.6540_RF43","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.4049\/jimmunol.161.6.2817","article-title":"Expansion of functional NK cells in multiple tissue compartments of mice treated with flt3-ligand: Implications for anti-cancer and anti-viral therapy","volume":"161","author":"Shaw","year":"1998","journal-title":"J. Immunol."},{"key":"10.1006\/jsre.2002.6540_RF44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","article-title":"The dendritic cell system and its role in immunogenicity","volume":"9","author":"Steinman","year":"1991","journal-title":"Annu. Rev. Immunol."},{"key":"10.1006\/jsre.2002.6540_RF45","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"2000","author":"Banchereau","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1006\/jsre.2002.6540_RF46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00062752-200105000-00004","article-title":"Role of hematopoietic growth factors\/flt3 ligand in expansion and regulation of dendritic cells","volume":"8","author":"McKenna","year":"2001","journal-title":"Curr. Opin. Hematol."},{"key":"10.1006\/jsre.2002.6540_RF47","first-page":"7","article-title":"The flt3\/flk2 ligand: Structure, functions, and prospects","volume":"9","author":"Fichelson","year":"1998","journal-title":"Eur. Cytokine Netw."},{"key":"10.1006\/jsre.2002.6540_RF48","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1084\/jem.184.5.1953","article-title":"Dramatic increase in the numbers of functionally mature dendritic cells in flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified","volume":"184","author":"Marakovsky","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1006\/jsre.2002.6540_RF49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/cimm.1997.1152","article-title":"Flt3 ligand induces the generation of functionally active dendritic cells in mice","volume":"179","author":"Shurin","year":"1997","journal-title":"Cell. Immunol."},{"key":"10.1006\/jsre.2002.6540_RF50","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.165.1.566","article-title":"Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo","volume":"165","author":"Pulendran","year":"2000","journal-title":"J. Immunol."},{"key":"10.1006\/jsre.2002.6540_RF51","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0301-472X(01)00722-6","article-title":"Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets","volume":"29","author":"Parajuli","year":"2001","journal-title":"Exp. Hematol."},{"key":"10.1006\/jsre.2002.6540_RF52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/cimm.2001.1773","article-title":"Regulation of T cell cytokine production by dendritic cells generated in vitro from hematopoietic progenitor cells","volume":"208","author":"Wesa","year":"2001","journal-title":"Cell. Immunol."},{"key":"10.1006\/jsre.2002.6540_RF53","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4049\/jimmunol.134.3.1644","article-title":"Interleukin 2 is both necessary and sufficient for the growth and differentiation of lectin-stimulated cytolytic T lymphocyte precursors","volume":"134","author":"Erard","year":"1985","journal-title":"J. Immunol."},{"key":"10.1006\/jsre.2002.6540_RF54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jnci\/82.2.143","article-title":"Phase II trial of high-dose intermittent interleukin-2 in renal cell carcinoma: A Southwest Oncology Group study","volume":"24","author":"Bukowski","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1006\/jsre.2002.6540_RF55","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1200\/JCO.1990.8.10.1650","article-title":"Interleukin-2 therapy in patients with metastatic malignant melanoma: A phase II study","volume":"8","author":"Parkinson","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/jsre.2002.6540_RF56","first-page":"2361","article-title":"Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2","volume":"56","author":"McLaughlin","year":"1996","journal-title":"Cancer Res."},{"key":"10.1006\/jsre.2002.6540_RF57","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.4049\/jimmunol.154.10.5282","article-title":"IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases","volume":"154","author":"Bronte","year":"1995","journal-title":"J. Immunol."},{"key":"10.1006\/jsre.2002.6540_RF58","first-page":"S67","article-title":"Potentiation of immunologic responsiveness to dendritic cell-based tumor vaccines by recombinant interleukin-2","volume":"6","author":"Shimizu","year":"2000","journal-title":"Cancer J. Sci. Am."},{"key":"10.1006\/jsre.2002.6540_RF59","first-page":"S109","article-title":"The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy","volume":"3","author":"Lotze","year":"1997","journal-title":"Cancer J. Sci. Am"},{"key":"10.1006\/jsre.2002.6540_RF60","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1084\/jem.188.11.2075","article-title":"Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant","volume":"188","author":"Pulendran","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1006\/jsre.2002.6540_RF61","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.leu.2402013","article-title":"Leukemic dendritic cells generated in the presence of flt3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia","volume":"15","author":"Woiciechowsky","year":"2001","journal-title":"Leukemia"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480402965406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480402965406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T14:19:16Z","timestamp":1682432356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480402965406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["S0022480402965406"],"URL":"https:\/\/doi.org\/10.1006\/jsre.2002.6540","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}